Cargando…

Mouse models of uveal melanoma: Strengths, weaknesses, and future directions

Uveal melanoma is the most common primary malignancy of the eye, and a number of discoveries in the last decade have led to a more thorough molecular characterization of this cancer. However, the prognosis remains dismal for patients with metastases, and there is an urgent need to identify treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Jackson R., Yoo, Jae Hyuk, Shin, Donghan, Odelberg, Shannon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065156/
https://www.ncbi.nlm.nih.gov/pubmed/31880399
http://dx.doi.org/10.1111/pcmr.12853
_version_ 1783505010361892864
author Richards, Jackson R.
Yoo, Jae Hyuk
Shin, Donghan
Odelberg, Shannon J.
author_facet Richards, Jackson R.
Yoo, Jae Hyuk
Shin, Donghan
Odelberg, Shannon J.
author_sort Richards, Jackson R.
collection PubMed
description Uveal melanoma is the most common primary malignancy of the eye, and a number of discoveries in the last decade have led to a more thorough molecular characterization of this cancer. However, the prognosis remains dismal for patients with metastases, and there is an urgent need to identify treatments that are effective for this stage of disease. Animal models are important tools for preclinical studies of uveal melanoma. A variety of models exist, and they have specific advantages, disadvantages, and applications. In this review article, these differences are explored in detail, and ideas for new models that might overcome current challenges are proposed.
format Online
Article
Text
id pubmed-7065156
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70651562020-03-16 Mouse models of uveal melanoma: Strengths, weaknesses, and future directions Richards, Jackson R. Yoo, Jae Hyuk Shin, Donghan Odelberg, Shannon J. Pigment Cell Melanoma Res Review Uveal melanoma is the most common primary malignancy of the eye, and a number of discoveries in the last decade have led to a more thorough molecular characterization of this cancer. However, the prognosis remains dismal for patients with metastases, and there is an urgent need to identify treatments that are effective for this stage of disease. Animal models are important tools for preclinical studies of uveal melanoma. A variety of models exist, and they have specific advantages, disadvantages, and applications. In this review article, these differences are explored in detail, and ideas for new models that might overcome current challenges are proposed. John Wiley and Sons Inc. 2020-01-22 2020-03 /pmc/articles/PMC7065156/ /pubmed/31880399 http://dx.doi.org/10.1111/pcmr.12853 Text en © 2020 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Richards, Jackson R.
Yoo, Jae Hyuk
Shin, Donghan
Odelberg, Shannon J.
Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title_full Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title_fullStr Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title_full_unstemmed Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title_short Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
title_sort mouse models of uveal melanoma: strengths, weaknesses, and future directions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065156/
https://www.ncbi.nlm.nih.gov/pubmed/31880399
http://dx.doi.org/10.1111/pcmr.12853
work_keys_str_mv AT richardsjacksonr mousemodelsofuvealmelanomastrengthsweaknessesandfuturedirections
AT yoojaehyuk mousemodelsofuvealmelanomastrengthsweaknessesandfuturedirections
AT shindonghan mousemodelsofuvealmelanomastrengthsweaknessesandfuturedirections
AT odelbergshannonj mousemodelsofuvealmelanomastrengthsweaknessesandfuturedirections